HLA class I and II antigens were determined, with the standard lymphocyte cytotoxicity test, in all patients and some relatives.
maximal repetitive nerve stimulation (SRNS) (> 1 1% decrement at the 3rd to 5th stimulus), and increased serum anti-AChR ab concentrations (>0.8 nM). In a patient with negative results on SRNS, single fibre EMG was performed.
HLA class I and II antigens were determined, with the standard lymphocyte cytotoxicity test, in all patients and some relatives.
Molecular analysis of DQ alleles was performed in all patients with myasthenia gravis. DQA1 alleles were identified by DNA amplification followed by hybridisation with allele specific oligonucleotide probes (ASO-PCR)6; DQB1 alleles were determined by a polymerase chain reaction-restriction fragment length polymorphism method. 7 There was no parents' consanguinity in any of the families.
Myasthenia gravis is generally sporadic. The frequency of familial cases is not well defined. It has been reported as between 3% and 5%,1'3 but the real rate is probably lower as, before the diagnostic use of anti-acetylcholine receptor antibody (anti-AChR ab) assay, genetically determined cases could have been erroneously included.
Studies have established that MHC genes play a major part in the development of some autoimmune disorders, but their relevance in susceptibility to myasthenia gravis is uncertain and, at present, under discussion. 4 Myasthenia gravis is often associated with other autoimmune diseases and up to 30% of patients have a positive family history of autoimmunity.5 This finding suggests hereditary factors predisposing to autoimmunity.
The familial occurrence of myasthenia gravis could be related to the transmission of HLA alleles. For this reason, family studies could be important to clarify the contribution of these genetic factors to the aetiology of the disease.
We describe four Italian families each with two patients with myasthenia gravis or related conditions.
Methods
The diagnosis of myasthenia gravis was based on typical history and signs, positive responses to the edrophonium test, supraFamily report FAMILY 1 Two sisters developed severe generalised myasthenia gravis at the ages of 15 and 19. They are also affected with epilepsy and one has psychosis. An edrophonium test and SRNS were positive and anti-AChR ab titre was >300 nM in both. One sister underwent thymectomy at the age of 22 with removal of a hyperplastic thymus. She improved considerably after surgery and, at present, has only mild symptoms under pyridostigmine and prednisone treatment. The other sister refused thymectomy; she is still severely affected despite high dose prednisone treatment. The HLA haplotype B8, DR3, DQ2, DQA1*0501, DQB1*0201, was present in both patients and in one healthy sister. FAMILY 2 Severe generalised myasthenia gravis developed in the mother and son. In the mother myasthenia gravis onset occurred at the age of 40. Diagnostic tests for myasthenia gravis were fulfilled and anti-AChR ab titre was 10-5 nM. Mediastinal CT was negative, so thymectomy was not performed. The patient improved greatly with pyridostigmine and prednisone treatment.
The son developed myasthenia gravis with severe bulbar and limb involvement at the age of 35, one year after removal of an invasive thymoma. An edrophonium test, SRNS, and vitiligo is present in two additional members and it seems to be paternally transmitted. The frequency of familial autoimmune myasthenia gravis is very low: in our experience it is less than 1 % (eight cases of myasthenia gravis or related conditions out of more than 800 patients). The few cases reported in the medical literature have generally occurred in siblings"3-"5 and an autosomal recessive inheritance has been suggested."3 From our data this genetic mechanism cannot be excluded even if an autosomal dominant mode seems to be operating in families 2 and 3. Moreover, familial occurrence of myasthenia gravis is not associated with a single clinical form and, as reported by other authors,"3 is not linked to a single HLA haplotype.
The frequent association of myasthenia gravis with other autoimmune diseases within the same family'6 suggests a more general predisposition to autoimmunity. This predisposing factor seems to be different from MHC genes.
